Kenvue Inc. KVUE | NYSE

$23.19 -$0.20 | -0.86%

After Hours
$23.21 $0.02 | 0.09%

Next Earnings: Oct 24, 2024

Company Overview:

Market Cap: $44.41B
PE Ratio: 40.68
52-Week Range: $17.67 - $23.55
Dividend Yield (FWD): 3.54% ($0.82)

1.4 Year Performance Metrics:

Total Return (with DRIP): -9.44% (-6.84% / yr)
Total Return (no DRIP): -10.06% (-7.29% / yr)
Share Price: -13.79%
Dividend Increase: 2.50%
KVUE 1.4-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

KVUE Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
KVUE Dividend CAGR:1Y: 2.50%2Y: N/A5Y: N/A10Y: N/A
Share Price
KVUE Price CAGR:1Y: 10.01%2Y: -7.15%5Y: -2.92%10Y: -1.47%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial. Cancel anytime.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Stock Comparison Tools
Dividend Stock Research
Dividend ETFs Research
Custom Dividend-centered Reports
YieldMax Holdings & Daily Trades
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial. Cancel anytime.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Stock Comparison Tools
Dividend Stock Research
Dividend ETFs Research
Custom Dividend-centered Reports
YieldMax Holdings & Daily Trades
Start Free Trial

KVUE Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - KVUE
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - KVUE
14-Day FREE Trial Get Full Access Now!

KVUE Earnings, Revenue, Cash & Debt, Shares Outstaning:

KVUE - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
KVUE - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
KVUE - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
KVUE - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
KVUE - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
KVUE - Cash & Debt
14-Day FREE Trial Get Full Access Now!
KVUE - Revenue
14-Day FREE Trial Get Full Access Now!
KVUE Revenue CAGR:1Y: -0.27%2Y: 2.54%5Y: N/A10Y: N/A
KVUE - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
KVUE EPS CAGR:1Y: -86.27%2Y: -70.20%5Y: N/A10Y: N/A
KVUE - Net Income
14-Day FREE Trial Get Full Access Now!
KVUE Net Income CAGR:1Y: -86.51%2Y: -68.62%5Y: N/A10Y: N/A
KVUE - EBITDA
14-Day FREE Trial Get Full Access Now!
KVUE EBITDA CAGR:1Y: 23.84%2Y: -6.39%5Y: N/A10Y: N/A
KVUE - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
KVUE Free Cash Flow CAGR:1Y: -47.37%2Y: -30.80%5Y: N/A10Y: N/A
KVUE - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
KVUE Free Cash Flow / Share CAGR:1Y: -47.37%2Y: -34.41%5Y: N/A10Y: N/A
KVUE - Gross Profit
14-Day FREE Trial Get Full Access Now!
KVUE Gross Profit CAGR:1Y: 5.89%2Y: N/A5Y: N/A10Y: N/A
KVUE - Expenses
14-Day FREE Trial Get Full Access Now!
KVUE CapEx CAGR:1Y: 16.88%2Y: 8.82%5Y: N/A10Y: N/A
KVUE - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
KVUE Shares Outstanding CAGR:1Y: 0.27%2Y: 5.78%5Y: N/A10Y: N/A
KVUE - Share Buybacks
14-Day FREE Trial Get Full Access Now!
KVUE Share Buybacks CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
KVUE - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
KVUE Stock-Based Comp CAGR:1Y: 60.53%2Y: 21.98%5Y: N/A10Y: N/A
KVUE - Dividends
14-Day FREE Trial Get Full Access Now!
KVUE Dividend CAGR:1Y: 2.50%2Y: N/A5Y: N/A10Y: N/A

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

KVUE - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
KVUE Actual Revenue CAGR:1Y: -0.27%2Y: 2.54%5Y: N/A10Y: N/A
KVUE - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
KVUE Actual EPS CAGR:1Y: -86.27%2Y: -70.20%5Y: N/A10Y: N/A
KVUE - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
KVUE Actual Net Income CAGR:1Y: -86.51%2Y: -68.62%5Y: N/A10Y: N/A
KVUE - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
KVUE Actual EBITDA CAGR:1Y: 23.84%2Y: -6.39%5Y: N/A10Y: N/A

Ratios, Profit Margins & Return on Capital:

KVUE - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
KVUE Net Profit Margin CAGR:1Y: -86.47%2Y: -69.39%5Y: N/A10Y: N/A
KVUE - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
KVUE Gross Profit Margin CAGR:1Y: 6.18%2Y: 2.01%5Y: N/A10Y: N/A
KVUE - Price to Earnings
14-Day FREE Trial Get Full Access Now!
KVUE - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
KVUE - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
KVUE - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

KVUE Dividends Info:

Annual Dividend: $0.82
Forward Yield: 3.54%
Ex-Dividend Date: 2024-08-14
Lifetime Dividens / Share: $1.01

KVUE Dividend History: Dates, Payments & Yield list

Below is a schedule of all KVUE dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/14/202408/28/2024$0.2053.8%3.87%$21.18
05/07/202405/22/2024$0.2003.98%3.98%$20.08
02/13/202402/28/2024$0.2003.12%4.16%$19.25
11/07/202311/22/2023$0.2002.04%4.08%$19.60
08/25/202309/07/2023$0.2000.87%3.48%$22.97

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial. Cancel anytime.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Stock Comparison Tools
Dividend Stock Research
Dividend ETFs Research
Custom Dividend-centered Reports
YieldMax Holdings & Daily Trades
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial. Cancel anytime.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Stock Comparison Tools
Dividend Stock Research
Dividend ETFs Research
Custom Dividend-centered Reports
YieldMax Holdings & Daily Trades
Start Free Trial

Projected Future Returns & Dividends for KVUE

Based on past 1.4-year performance, here are KVUE growth metrics:

Share price CAGR of +10.11%
Dividend CAGR of +0.25%
Using KVUE CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

KVUE
Current Price$23.19
Start Shares431.22
Start Value$10,000
 
After 10 years:
Final Share Count547.92
Dividends Payment$0.21
Annual Dividends$461
Yield on cost4.61%
Share Price$55.19
Total Dividends$4,104
Final Value$30,241

Estimated Future Value + Dividends - KVUE

NOTE: Above numbers are our estimate based on KVUE's Dividend and Price CAGR over past 1.4 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Kenvue Inc. (KVUE) had its IPO on 2023-05-04, and is trader on NYSE stock exchange.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

KVUE website: https://www.kenvue.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial. Cancel anytime.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Stock Comparison Tools
Dividend Stock Research
Dividend ETFs Research
Custom Dividend-centered Reports
YieldMax Holdings & Daily Trades
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial. Cancel anytime.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Stock Comparison Tools
Dividend Stock Research
Dividend ETFs Research
Custom Dividend-centered Reports
YieldMax Holdings & Daily Trades
Start Free Trial